Largest health care pharmaceutical companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 health care pharmaceutical companies ranked by net assets, at SGD 111.7B, ahead of Johnson & Johnson (SGD 105.3B) and Sanofi (SGD 102.3B). Figures as of 19 Nov 2026, 15:57 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerSGD 111.7B
- Median
- SGD 1.1B
- Combined market value
- SGD 6.4T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | SGD 111.7B | SGD 203.4B | SGD 35.68 | 1.53% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | SGD 105.3B | SGD 824.8B | SGD 342.62 | 2.71% down | 34% up | ||
| 3 | SanofiSNY · Health Care | SGD 102.3B | SGD 142.6B | SGD 59.38 | 2.42% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | SGD 67.9B | SGD 426.5B | SGD 173.00 | 2.77% down | 45% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | SGD 67.3B | SGD 233.8B | SGD 135.00 | 0.06% up | 16% down | ||
| 6 | AstraZenecaAZN · Health Care | SGD 62.8B | SGD 350.5B | SGD 226.02 | 2.09% down | 1% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | SGD 60.1B | SGD 88.2B | SGD 27.62 | 0.56% up | 51% up | ||
| 8 | NovartisNVS · Health Care | SGD 59.6B | SGD 369B | SGD 195.37 | 2.53% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | SGD 40.4B | SGD 123.5B | SGD 1,193.91 | 2.22% down | 28% up | ||
| 10 | Novo NordiskNVO · Health Care | SGD 37.2B | SGD 222.2B | SGD 50.41 | 1.00% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | SGD 34.3B | SGD 1.55T | SGD 1,742.57 | 2.41% down | 33% up | ||
| 12 | GSKGSK · Health Care | SGD 28.1B | SGD 123.8B | SGD 61.75 | 1.56% down | 5% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | SGD 24.1B | SGD 171.5B | SGD 676.43 | 2.35% down | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | SGD 23.9B | SGD 153.8B | SGD 75.23 | 2.18% down | 30% up | ||
| 15 | ViatrisVTRS · Health Care | SGD 19B | SGD 29.3B | SGD 25.56 | 2.39% down | 99% up | ||
| 16 | Royalty PharmaRPRX · Health Care | SGD 12.5B | SGD 50.3B | SGD 87.48 | 1.35% down | 79% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 10.2B | SGD 60B | SGD 51.45 | 5.66% down | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | SGD 9.2B | SGD 30.6B | SGD 718.29 | 3.66% down | 22% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | SGD 8.5B | SGD 17.2B | SGD 34.48 | 0.00% | 26% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | SGD 7.9B | SGD 15.7B | SGD 81.05 | 2.17% up | 17% up | ||
| 21 | GrifolsGRFS · Health Care | SGD 7.6B | SGD 7.3B | SGD 10.71 | 2.13% down | 0% up | ||
| 22 | GenmabGMAB · Health Care | SGD 7.6B | SGD 41B | SGD 66.52 | 1.06% up | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | SGD 5.8B | SGD 36.6B | SGD 50.57 | 1.11% up | 91% up | ||
| 24 | BeOne MedicinesONC · Health Care | SGD 5.6B | SGD 59.1B | SGD 517.68 | 0.67% down | 16% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 5.6B | SGD 19.9B | SGD 309.31 | 3.33% down | 41% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 5.2B | SGD 16B | SGD 19.14 | 1.08% down | 8% up | ||
| 27 | ZoetisZTS · Health Care | SGD 4.3B | SGD 43.3B | SGD 106.60 | 3.53% down | 26% down | ||
| 28 | AlkermesALKS · Health Care | SGD 2.3B | SGD 10B | SGD 59.35 | 1.90% down | 66% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | SGD 1.3B | SGD 7.5B | SGD 373.24 | 3.24% down | 50% up | ||
| 30 | Legend BiotechLEGN · Health Care | SGD 1.3B | SGD 4B | SGD 20.53 | 2.15% down | 41% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | SGD 1.1B | SGD 11.4B | SGD 407.63 | 3.43% up | 86% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | SGD 1B | SGD 25.5B | SGD 190.58 | 1.22% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | SGD 995M | SGD 7.9B | SGD 195.37 | 3.16% down | 43% up | ||
| 34 | InsmedINSM · Health Care | SGD 954.3M | SGD 39.2B | SGD 178.85 | 15.61% up | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | SGD 923.6M | SGD 12B | SGD 126.64 | 3.35% down | 332% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | SGD 850.8M | SGD 10.9B | SGD 13.61 | 0.38% up | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | SGD 836.8M | SGD 12.9B | SGD 85.27 | 0.13% down | 117% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | SGD 836.5M | SGD 9.2B | SGD 84.02 | 4.02% down | 10% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | SGD 821.8M | SGD 6.3B | SGD 35.96 | 0.14% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | SGD 793.8M | SGD 10.6B | SGD 163.07 | 0.69% down | 51% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 778.3M | SGD 11.9B | SGD 514.27 | 0.04% up | 27% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 733M | SGD 9.6B | SGD 121.76 | 0.80% down | 129% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | SGD 674.4M | SGD 5.7B | SGD 52.47 | 1.79% down | 86% up | ||
| 44 | ABIVAXABVX · Health Care | SGD 652.2M | SGD 9.6B | SGD 109.30 | 0.97% up | 32% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | SGD 637.2M | SGD 6.2B | SGD 110.01 | 1.44% up | 108% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | SGD 631.6M | SGD 5.8B | SGD 34.81 | 1.59% down | 63% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | SGD 609.4M | SGD 8.6B | SGD 126.30 | 2.16% up | 255% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 601.8M | SGD 7.9B | SGD 56.04 | 0.66% up | 13% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | SGD 429.2M | SGD 5B | SGD 36.88 | 1.92% down | 168% up | ||
| 50 | ErascaERAS · Health Care | SGD 419.9M | SGD 6.3B | SGD 18.01 | 1.38% up | 395% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | SGD 406.4M | SGD 7.9B | SGD 120.90 | 1.22% up | 34% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 179.6M | SGD 10.5B | SGD 151.05 | 1.74% down | 18% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | SGD 148.3M | SGD 6.1B | SGD 63.86 | 1.56% down | 45% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | SGD 114M | SGD 9.1B | SGD 172.10 | 0.54% down | 6% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -SGD 91.4M | SGD 9.6B | SGD 27.49 | 2.70% down | 90% up | ||
| 56 | VeradermicsMANE · Health Care | -SGD 156.3M | SGD 6.7B | SGD 159.97 | 0.79% down | 231% up | ||
| 57 | Ascendis PharmaASND · Health Care | -SGD 233.3M | SGD 22.5B | SGD 342.98 | 1.75% down | 29% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -SGD 265.1M | SGD 6.5B | SGD 77.24 | 0.69% down | 21% down | ||
| 59 | CytokineticsCYTK · Health Care | -SGD 851.8M | SGD 9.1B | SGD 65.47 | 1.21% down | 19% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -SGD 2.7B | SGD 19.7B | SGD 101.35 | 0.60% up | 21% up | ||
| 61 | AbbVieABBV · Health Care | -SGD 4.2B | SGD 639.9B | SGD 361.99 | 1.99% down | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2913 SGD).
Questions and answers
Which health care pharmaceutical companies rank first by net assets?
Pfizer (SGD 111.7B), Johnson & Johnson (SGD 105.3B) and Sanofi (SGD 102.3B) are the top three of the 61 health care pharmaceutical companies ranked by net assets as of 19 Nov 2026, 15:57 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by net assets.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by net assets have a combined market value of SGD 6.4T as of 19 Nov 2026, 15:57 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by net assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.